Search Results 1021-1030 of 21156 for Informed consent

1. Study To Assess The Efficacy, Safety, And Tolerability Of NOC-110 In Adults With Refractory Or Unexplained Chronic Cough - Mayo Clinic

   * Able to provide Informed Consent. Exclusion Criteria: * Previous exposure to taplucainium (formerly NTX-1175) or known allergy or hypersensitivity to ...

2. ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack - Mayo Clinic

   Age 18 years or above at the time of signing the informed consent -Hospitalisation for acute myocardial infarction with evidence of type 1 MI (myocardial ...

3. Computerized Cognitive Test to Screen for Cognitive Changes in Patients with Multiple Myeloma - Mayo Clinic

   Provide written informed consent. Exclusion Criteria: Unwillingness or inability to undergo cognitive testing; Other diagnosed medical conditions that might ...

4. A Study in Second Line Metastatic Colorectal Cancer - Mayo Clinic

   Ability to provide signed informed consent. Exclusion Criteria. Receipt of bevacizumab ≤ 28 days prior to randomization; Receipt of any investigational ...

5. Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) - Mayo Clinic

   Written informed consent; Participants ≥18 years of age or the minimum legal adult age (whichever is greater) at the time the informed consent form is signed.

6. A Study of Macitentan in Pulmonary Hypertension After Left Ventricular Assist Device Implantation - Mayo Clinic

   Written informed consent prior to initiation of any study-mandated procedure; Males or females ≥ 18 years of age; Surgical implantation of LVAD (e.g. ...

7. Study of Vorasidenib (AG-881) in Participants With Residual or Recurrent Grade 2 Glioma With an IDH1 or IDH2 Mutation (INDIGO) - Mayo Clinic

   A parent or legal guardian must sign informed consent for adolescent subjects who sign assent. Note: Subjects who do not read and/or speak one of the ...

8. SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors - Mayo Clinic

   Have read, understood, and documented written informed consent/assent 5. Be able to provide medical evidence through prior medical history of previous

9. Bentracimab (PB2452) In Ticagrelor-treated Patients With Uncontrolled Major Or Life-Threatening Bleeding Or Requiring Urgent Surgery Or Invasive Procedure - Mayo Clinic

   Male or female ≥ 18 years of age with documented or verbal informed consent. History or documentation of ticagrelor intake within the prior 3 days ...

10. Study of Imprime PGG and Pembrolizumab in Advanced Melanoma and Triple Negative Breast Cancer - Mayo Clinic

    Has a known psychiatric or substance abuse disorder(s) that would interfere with informed consent or cooperation with the requirements of the trial; Is ...